THE IMPORTANCE OF CIRCULATING TUMOR DNA IN THE ASSESSMENT OF METASTATIC COLORECTAL CANCER TREATMENT EFFECTIVNE

THE IMPORTANCE OF CIRCULATING TUMOR DNA IN THE ASSESSMENT OF METASTATIC COLORECTAL CANCER TREATMENT EFFECTIVNE

Challenges in cancer detection, prognosis and management are currently being solved by determining circulating tumor DNA (ctDNA). The assessment of this marker has acquired particular importance in metastatic colorectal cancer (mCRC), the systemic treatment of which depends on the RAS gene status, w...

Full description

Bibliographic Details
Main Authors:	M. I. Sluzhev, V. V. Semiglazov, T. Yu. Semiglazova, E. V. Tkachenko, S. A. Protsenko, D. Kh. Latipova, S. V. Kondratev, N. A. Brish, Yu. V. Alekseeva, A. M. Belyaev
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2021-10-01
Series:	Сибирский онкологический журнал
Subjects:	метастатический колоректальный рак циркулирующие опухолевые днк мутации ras ингибиторы egfr
Online Access:	https://www.siboncoj.ru/jour/article/view/1928

Similar Items

CELL MEDIATED IMMUNITY IN PATIENTS WITH STAGE II–IV COLORECTAL CANCER WITH OR WITHOUT CIRCULATING TUMOR CELLS
by: E. Y. Zlatnik, et al.
Published: (2020-09-01)

The association between detection the presence of KRAS mutations in tumors and circulating tumor cells from patients with colorectal cancer
by: O. I. Kit, et al.
Published: (2016-02-01)

Lechenie metastazov kolorektal'nogo raka v pecheni
by: Yu I Patyutko, et al.
Published: (2009-06-01)

EGFR inhibitors in the treatment of colorectal cancer
by: M. В. Zabelin, et al.
Published: (2018-09-01)

Circulating tumor cells in breast cancer: clinical and molecular parallels
by: A. V. Zyuzyukina, et al.
Published: (2021-09-01)

Prolongirovannaya blokada angiogeneza pri metastaticheskom kolorektal'nom rake (novye dannye)
by: E V Artamonova
Published: (2013-09-01)

Signs of apoptosis in circulating tumor cell subpopulations with phenotypes associated with stemness and epithelial-mesenchymal transition in breast carcinoma
by: V. M. Perelmuter, et al.
Published: (2022-12-01)

Overall survival in colon cancer patients with different levels of circulating tumor cells and feasibility of enhancing its prognostic value
by: O. I. Kit, et al.
Published: (2022-09-01)

Nivolumab monotherapy in metastatic colorectal cancer: current approaches to response evaluation
by: N. N. Babyshkina, et al.
Published: (2022-11-01)

The role of liquid biopsy in the diagnosis of glioblastoma progression
by: A. I. Ryabova, et al.
Published: (2022-06-01)

Gefitinib – terapiya vybora 1-y linii nemelkokletochnogo raka legkogo u bol'nykh s nalichiem mutatsiy v gene EGFR
by: Larisa Vladimirovna Bolotina
Published: (2013-09-01)

CXCR4 EXPRESSION IN DIFFERENT SUBSETS OF CTCs AND SINGLE (DETACHED) BREAST CANCER CELLS
by: O. E. Savelieva, et al.
Published: (2018-09-01)

Comparative analysis of tumor control gene and microRNA expression profiles in tumor and adjacent tissues in patients with colorectal cancer
by: M. I. Sluzhev, et al.
Published: (2022-05-01)

Dynamics of circulating tumor cells during neoadjuvant chemotherapy in patients with locally-advanced breast cancer
by: Yu N Nenakhova, et al.
Published: (2017-09-01)

Hormone therapy for premenopausal women with metastatic breast cancer: combinations with cyclin-dependent kinase inhibitors
by: E. V. Artamonova, et al.
Published: (2019-09-01)

Оксалиплатин в химиотерапии рака толстой кишки: клиникоэкономический анализ
Published: (2018-06-01)

The prognostic value of circulating in blood tumor DNA as a marker of minimal residual disease in stage I–III colorectal cancer
by: E. M. Polyanskaya, et al.
Published: (2022-06-01)

APPLICATION OF HEMOFILTERCYTOLOGICAL TESTS FOR ASSIGNING ADJUVANT POLYCHEMOTHERAPHY TO CANCER PATIENTS AND EVALUATING ITS EFFICACY
by: Георгий Цыренович Дамбаев, et al.
Published: (2022-03-01)

Role of liquid biopsy in the detection and monitoring of cervical cancer
by: E. V. Kayukova
Published: (2019-04-01)

Health technology assessment of colorectal cancer chemotherapy with afl ibercept
by: A. S. Kolbin, et al.
Published: (2018-05-01)

Condition of the humoral link of immune system at patients with endometrial cancer
by: A. V. Efremov, et al.
Published: (2014-08-01)

CDK4/6 inhibitors in the treatment of metastatic breast cancer. Choosing optimal therapy for estrogen-receptor-positive HER2-negative metastatic breast cancer: analysis of doctors’ preferences (“Prometheus”) in Russia – first results of the survey
by: E. V. Artamonova, et al.
Published: (2021-01-01)

Molecular-genetic mechanisms of the signal cascade RAS-RAF-MEK-ERK associated with the development of the tumor process and the purpose of targeted drugs for colorectal cancer
by: A. N. Toropovsky, et al.
Published: (2021-08-01)

Mutational profile of KRAS-positive colorectal cancer
by: E. N. Telysheva, et al.
Published: (2022-03-01)

THE PRESENCE OF VARIOUS POPULATIONS OF CIRCULATING TUMOR CELLS IN THE BLOOD OF BREAST CANCER PATIENTS BEFORE TREATMENT: ASSOCIATION WITH FIVE-YEAR METASTASIS-FREE SURVIVAL
by: E. V. Kaigorodova, et al.
Published: (2020-12-01)

Liquid biopsy of colorectal cancer: a new approach to evaluation of aberrant methylation of the <i>SEPT9</i> gene
by: I. V. Botezatu, et al.
Published: (2021-12-01)

Target liquid biopsy using “enriched” polymerase chain reaction and DNA melting analysis
by: I. V. Botezatu, et al.
Published: (2018-05-01)

Сорафениб в последовательной терапии метастатического рака почки
Published: (2019-09-01)

Circulating tumor cells in oncology
by: D. I. Vodolazhsky, et al.
Published: (2022-06-01)

NEW DIAGNOSTIC POSSIBILITIES AND TRADITIONAL POSITIONS IN MODERN ONCOLOGY
by: Анатолий Агванович Чимитов, et al.
Published: (2021-09-01)

Brain metastases from esophageal cancer: a case-report
by: N. V. Sevian, et al.
Published: (2020-07-01)

Clinical case use bevacizumab for patient with metastatic ovarian cancer
by: M. R. Oganyan, et al.
Published: (2014-07-01)

Highly sensitive scanning of gene mutations: TaqMan probes as blocking agents
by: I. V. Botezatu, et al.
Published: (2016-06-01)

Afatinib: new treatment options for lung cancer with activating EGFR mutations
by: M. V. Stepanchenko, et al.
Published: (2015-12-01)

Neuroendocrine tumors of the vagina
by: S. O. Nikogosyan, et al.
Published: (2015-09-01)

Prognostic Value of BRCA1 and BRCA2 Gene Mutations in Prostate Cancer: a Literature Review
by: M. V. Loginova, et al.
Published: (2021-05-01)

Taktika vedeniya bol'nogo metastaticheskim kolorektal'nym rakom s izolirovannymi metastazami v pechen'
by: A A Tryakin
Published: (2009-09-01)

Detection of gene mutations in genome “hot” spots: “hairpin” amplicons in DNA melting analysis
by: V. N. Kondratova, et al.
Published: (2017-04-01)

PALBOCICLIB IN COMBINATION WITH HORMONE THERAPY FOR LUMINAL HER2-NEGATIVE METASTATIC BREAST CANCER: NEW HIGHLY EFFECTIVE STRATEGY OF DRUG TREATMENT
by: E. V. Artamonova
Published: (2017-09-01)

Многолетний опыт лечения рецидивов рака шейки матки
by: А. Шумейкина, et al.
Published: (2022-06-01)